Blankson JN - Search Results

1

Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA.

Simonetti FR, White JA, Tumiotto C, Ritter KD, Cai M, Gandhi RT, Deeks SG, Howell BJ, Montaner LJ, Blankson JN, Martin A, Laird GM, Siliciano RF, Mellors JW, Siliciano JD. Simonetti FR, et al. Among authors: blankson jn. Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18692-18700. doi: 10.1073/pnas.2006816117. Epub 2020 Jul 20. Proc Natl Acad Sci U S A. 2020. PMID: 32690683 Free PMC article.

2

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF. Finzi D, et al. Nat Med. 1999 May;5(5):512-7. doi: 10.1038/8394. Nat Med. 1999. PMID: 10229227

3

Interleukin 2 treatment for HIV infection.

Blankson J, Siliciano RF. Blankson J, et al. JAMA. 2000 Jul 12;284(2):236-8. doi: 10.1001/jama.284.2.236. JAMA. 2000. PMID: 10889599 No abstract available.

4

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Pierson T, Hoffman TL, Blankson J, Finzi D, Chadwick K, Margolick JB, Buck C, Siliciano JD, Doms RW, Siliciano RF. Pierson T, et al. J Virol. 2000 Sep;74(17):7824-33. doi: 10.1128/jvi.74.17.7824-7833.2000. J Virol. 2000. PMID: 10933689 Free PMC article.

5

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.

Blankson JN, Finzi D, Pierson TC, Sabundayo BP, Chadwick K, Margolick JB, Quinn TC, Siliciano RF. Blankson JN, et al. J Infect Dis. 2000 Dec;182(6):1636-42. doi: 10.1086/317615. Epub 2000 Nov 8. J Infect Dis. 2000. PMID: 11069234

6

Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.

Blankson JN, Gallant JE, Siliciano RF. Blankson JN, et al. J Infect Dis. 2001 Feb 15;183(4):657-61. doi: 10.1086/318545. Epub 2001 Jan 12. J Infect Dis. 2001. PMID: 11170994

7

MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.

Blankson JN, Siliciano RF. Blankson JN, et al. J Clin Invest. 2001 Mar;107(5):549-51. doi: 10.1172/JCI12430. J Clin Invest. 2001. PMID: 11238554 Free PMC article. No abstract available.

8

The challenge of viral reservoirs in HIV-1 infection.

Blankson JN, Persaud D, Siliciano RF. Blankson JN, et al. Annu Rev Med. 2002;53:557-93. doi: 10.1146/annurev.med.53.082901.104024. Annu Rev Med. 2002. PMID: 11818490 Review.

9

Loss of HIV-1-specific immunity during treatment interruption in 2 chronically infected patients.

Blankson JN, Gallant JE, Quinn TC, Bartlett JG, Siliciano RF. Blankson JN, et al. JAMA. 2002 Jul 10;288(2):162-4. doi: 10.1001/jama.288.2.162-a. JAMA. 2002. PMID: 12095377 No abstract available.

10

Structured therapeutic interruptions: a review.

Blankson JN, Siliciano RF. Blankson JN, et al. Hopkins HIV Rep. 2001 Jan;13(1):1, 8-9, 13. Hopkins HIV Rep. 2001. PMID: 12184252 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page